Literature DB >> 3524286

High level of sensitivity to chloroquine of 72 Plasmodium falciparum isolates from southern Cameroon in January 1985.

P Brasseur, P Druilhe, J Kouamouo, O Brandicourt, M Danis, S R Moyou.   

Abstract

The sensitivity to chloroquine, quinine and mefloquine of Plasmodium falciparum isolates from 3 areas of southwest Cameroon was evaluated using an in vitro microtest with estimation of parasite growth by 3H-hypoxanthine incorporation. Among 2,429 children examined, P. falciparum was found on thin smears in 124 of them, 76 isolates were submitted to in vitro tests and 72 were successful. In the locations studied, some of which are close to the area of Limbe where in vivo resistance has been reported, all 72 isolates were found fully sensitive to low concentrations of chloroquine (mean EC50 5.9 ng/ml or 18.5 nmol/l of medium). In 47 of these isolates simultaneously tested using WHO microtest predosed plates, the sensitivity was identical. Out of 39 tests performed with quinine, 35 were successful. While most strains responded to low concentrations, some showed a decreased sensitivity to the drug, the EC50 of 4 of them being in the range 230-300 nmol/l. Each of the 17 isolates tested with mefloquine was susceptible to very low concentrations of freshly prepared drug solution. While chloroquine-resistant strains may already exist in Cameroon, the present study suggests that they would be restricted to a limited area and are not widespread. Data also suggest that monitoring of the sensitivity of P. falciparum to quinine might soon be necessary.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3524286     DOI: 10.4269/ajtmh.1986.35.711

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

1.  Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies.

Authors:  A Moreno; E Badell; N Van Rooijen; P Druilhe
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Plasmodium falciparum in vitro susceptibility to antimalarial drugs in Casamance (southwestern Senegal) during the first 5 years of routine use of artesunate-amodiaquine.

Authors:  P Agnamey; P Brasseur; P Eldin de Pecoulas; Michel Vaillant; P Olliaro
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 3.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

4.  In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos).

Authors:  Mayfong Mayxay; Marion Barends; Alan Brockman; Anchalee Jaidee; Shalini Nair; Dan Sudimack; Tiengkham Pongvongsa; Samlane Phompida; Rattanaxay Phetsouvanh; Tim Anderson; Nicholas J White; Paul N Newton
Journal:  Am J Trop Med Hyg       Date:  2007-02       Impact factor: 2.345

5.  Enhancement of drug susceptibility in Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors.

Authors:  A M Ndifor; R E Howells; P G Bray; J L Ngu; S A Ward
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

6.  Susceptibility of Plasmodium falciparum to different doses of quinine in vivo and to quinine and quinidine in vitro in relation to chloroquine in Liberia.

Authors:  A Björkman; M Willcox; N Marbiah; D Payne
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

7.  Curative and preventive treatment of uncomplicated malaria in public health institutions in Cameroon.

Authors:  P M Ndumbe
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

8.  C-reactive protein protects against preerythrocytic stages of malaria.

Authors:  S Pied; A Nussler; M Pontent; F Miltgen; H Matile; P H Lambert; D Mazier
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

9.  Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.

Authors:  Wilfred F Mbacham; Marie-Solange B Evehe; Palmer M Netongo; Isabel A Ateh; Patrice N Mimche; Anthony Ajua; Akindeh M Nji; Domkam Irenee; Justin B Echouffo-Tcheugui; Bantar Tawe; Rachel Hallett; Cally Roper; Geoffrey Targett; Brian Greenwood
Journal:  Malar J       Date:  2010-01-27       Impact factor: 2.979

10.  Geometric least squares means ratios for the analysis of Plasmodium falciparum in vitro susceptibility to antimalarial drugs.

Authors:  Michel Vaillant; Piero Olliaro
Journal:  Malar J       Date:  2007-11-26       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.